Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 8.25%4B | 11.51%2.67B | 7.45%1.21B | 63.19%4.96B | 82.61%3.7B | 74.36%2.39B | 32.74%1.12B | -27.50%3.04B | -38.49%2.02B | -23.38%1.37B |
| Operating revenue | 8.25%4B | 11.51%2.67B | 7.45%1.21B | 63.19%4.96B | 82.61%3.7B | 74.36%2.39B | 32.74%1.12B | -27.50%3.04B | -38.49%2.02B | -23.38%1.37B |
| Total operating cost | 0.13%5.23B | -2.79%3.4B | -1.21%1.65B | 21.19%7.19B | 25.97%5.23B | 36.04%3.5B | 38.49%1.67B | 5.38%5.93B | -4.21%4.15B | 12.08%2.57B |
| Operating cost | -0.30%4.56B | -3.41%2.94B | -6.13%1.37B | 22.90%6.14B | 35.07%4.57B | 51.84%3.04B | 41.56%1.46B | 2.80%4.99B | -10.25%3.39B | -2.17%2B |
| Operating tax surcharges | 3.68%25.61M | 4.43%17.16M | 4.07%8.52M | -1.27%32.83M | -1.75%24.7M | -5.32%16.43M | -13.20%8.19M | 81.75%33.26M | 152.29%25.14M | 74.99%17.35M |
| Operating expense | -0.83%25.18M | -1.73%16.78M | -1.74%8.17M | 6.48%35.02M | 0.64%25.39M | 3.68%17.08M | -0.61%8.31M | -21.57%32.89M | -19.24%25.23M | -4.59%16.47M |
| Administration expense | -2.44%84.51M | -2.16%56M | -5.36%24.47M | -1.02%109.38M | -2.93%86.63M | 0.24%57.24M | -0.07%25.86M | -8.31%110.51M | -2.20%89.24M | 0.16%57.1M |
| Financial expense | 3.69%412.45M | -1.15%293.85M | 48.08%199.32M | 14.64%665.12M | -16.94%397.77M | -21.51%297.27M | 72.85%134.6M | 53.91%580.18M | 52.67%478.89M | 295.92%378.76M |
| -Interest expense (Financial expense) | -23.71%357.35M | -18.57%236.55M | -0.07%140.22M | 23.55%647.14M | 22.08%468.38M | 14.59%290.49M | 9.90%140.32M | 68.92%523.81M | 84.79%383.66M | 124.21%253.5M |
| -Interest Income (Financial expense) | 63.57%-6.54M | 69.88%-4.16M | 77.80%-1.43M | -287.67%-24.2M | -388.72%-17.95M | -472.88%-13.82M | -430.67%-6.44M | 52.70%-6.24M | 62.78%-3.67M | 68.09%-2.41M |
| Research and development | 6.12%124.6M | 14.23%83.15M | 16.63%38.34M | 15.41%208.37M | -18.16%117.42M | -28.36%72.79M | -37.68%32.87M | -15.24%180.55M | 28.78%143.48M | 46.10%101.61M |
| Credit Impairment Loss | 123.61%630.42K | -845.14%-720.44K | 591.33%902.59K | -314.67%-3.94M | -184.02%-2.67M | -102.32%-76.23K | -112.05%-183.7K | 148.66%1.83M | 634.75%3.18M | 82.69%3.28M |
| Asset Impairment Loss | 39.47%-173.82M | 35.34%-129.07M | 27.18%-82.02M | 20.00%-352.4M | 16.82%-287.14M | -28.32%-199.62M | -15.51%-112.64M | -28.05%-440.51M | -308.58%-345.2M | -99.59%-155.57M |
| Other net revenue | ||||||||||
| Fair value change income | -52.11%1.11M | -44.22%2.27M | -87.66%164.93K | 129.81%1.44M | -25.37%2.31M | -66.45%4.08M | -85.06%1.34M | -97.10%626.03K | -64.84%3.1M | -28.34%12.15M |
| Invest income | -27.65%10.1M | 8.22%6M | 110.96%4.19M | -62.93%19.88M | -66.90%13.96M | -74.58%5.55M | -81.08%1.98M | -56.09%53.63M | -62.12%42.18M | -69.27%21.83M |
| Asset deal income | -100.09%-12.59K | ---12.59K | ---- | --13.85M | --13.85M | ---- | ---- | ---- | ---- | ---- |
| Other revenue | -9.12%21.97M | -11.61%14.56M | -21.89%7M | -17.91%31.77M | -20.73%24.18M | -26.04%16.48M | 30.43%8.96M | 13.21%38.7M | 27.96%30.5M | 31.47%22.28M |
| Operating profit | 22.32%-1.37B | 34.36%-840.02M | 20.98%-507.59M | 22.21%-2.52B | 26.20%-1.76B | 1.26%-1.28B | -50.89%-642.35M | -102.01%-3.24B | -143.86%-2.39B | -173.05%-1.3B |
| Add:Non operating Income | -77.13%304.2K | -75.38%299.4K | -95.71%36K | 60.67%1.36M | 78.05%1.33M | 129.90%1.22M | 418.00%839.15K | -72.59%847.19K | -52.40%747.19K | -52.75%529K |
| Less:Non operating expense | 495.22%19.99K | 411.65%17.19K | 255.35%11.94K | -99.82%11.56K | -99.76%3.36K | -99.33%3.36K | -98.63%3.36K | 304.79%6.5M | 30.00%1.41M | 45.49%500.57K |
| Total profit | 22.28%-1.37B | 34.32%-839.73M | 20.88%-507.57M | 22.39%-2.52B | 26.27%-1.76B | 1.35%-1.28B | -50.66%-641.51M | -102.55%-3.24B | -144.05%-2.39B | -173.49%-1.3B |
| Net profit | 22.28%-1.37B | 34.32%-839.73M | 20.88%-507.57M | 22.39%-2.52B | 26.27%-1.76B | 1.35%-1.28B | -50.66%-641.51M | -102.55%-3.24B | -144.05%-2.39B | -173.49%-1.3B |
| Net profit from continuing operation | 22.28%-1.37B | 34.32%-839.73M | 20.88%-507.57M | 22.39%-2.52B | 26.27%-1.76B | 1.35%-1.28B | -50.66%-641.51M | -102.55%-3.24B | -144.05%-2.39B | -173.49%-1.3B |
| Net profit of parent company owners | 22.28%-1.37B | 34.32%-839.73M | 20.88%-507.57M | 22.39%-2.52B | 26.27%-1.76B | 1.35%-1.28B | -50.66%-641.51M | -102.55%-3.24B | -144.05%-2.39B | -173.49%-1.3B |
| Earning per share | ||||||||||
| Basic earning per share | 23.08%-0.1 | 33.33%-0.06 | 20.00%-0.04 | 21.74%-0.18 | 23.53%-0.13 | 0.00%-0.09 | -66.67%-0.05 | -91.67%-0.23 | -142.86%-0.17 | -200.00%-0.09 |
| Diluted earning per share | 23.08%-0.1 | 33.33%-0.06 | 20.00%-0.04 | 21.74%-0.18 | 23.53%-0.13 | 0.00%-0.09 | -66.67%-0.05 | -91.67%-0.23 | -142.86%-0.17 | -200.00%-0.09 |
| Other composite income | ||||||||||
| Total composite income | 22.28%-1.37B | 34.32%-839.73M | 20.88%-507.57M | 22.39%-2.52B | 26.27%-1.76B | 1.35%-1.28B | -50.66%-641.51M | -102.55%-3.24B | -144.05%-2.39B | -173.49%-1.3B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | -- | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | -- | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.